The Swiss Medicines Verification Organisation (SMVO) is committed to protect patients against counterfeit medicines. The affected associations of the Swiss health care system founded the SMVO on 4 April 2018.
Purpose of the association:
The following main tasks have been defined in the SMVO Articles of Association:
- Ensuring patient safety and health care system improvements by cooperation and participation of all affected stakeholders.
- Ensuring that the statutory provisions of the HMG, the implementation guidelines of the Delegated Regulation (EU) 2016/161 and the specifications provided by EMVO, are applied.
- Single point of contact for the authorities and contract partners of the EMVO.
- Responsibility for the SMVS strategy (design, controlling and risk management).
- Appoint the SMVS management.
- Definition of the SMVS operating cost allocation rules to invoice the affected MAHs.
The SMVO is the 100% shareholder of the NMVS Operating Company (SMVS Schweizerische Gesellschaft für die Verifizierung von Arzneinmittlen GmbH) which runs the database system.
The following associations are members of SMVO:
- ASSGP, Swiss Association for Self-Medication
- FMH, connection of Swiss Medical Doctors
- GRIP, Groupement Romand de l'industrie pharmaceutique
- GSASA, Swiss Association of Office and Hospital Pharmacists
- H +, The Swiss hospitals
- Intergenerika, Association of Generics Companies of Switzerland
- interpharma, the association of research-based pharmaceutical companies in Switzerland
- pharmalog, Swiss Pharma Logistics Association
- pharmasuisse, Swiss Pharmacy Association
- scienceindustries, Association of the Chemical, Pharmaceutical and Biotech Industries
- SVKH, The Swiss Association for Complementary Medicinal Products
- vips, association of pharmaceutical companies in Switzerland